Judge Joshua Roberts of the Philadelphia Court of Common Pleas denied plaintiffs' motion for his recusal from the Zantac mass tort in an Aug. 15 order, ruling that he could remain impartial in the litigation. However, he suggested his ruling should go to an appeals court sooner rather than later to address what could be an important but tricky legal issue.
Biotech & Pharmaceuticals
August 19, 2024, 2:30 PM